A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension

NCT06423352 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild to Moderate Hypertension

Interventions

DRUG: Zilebesiran
DRUG: Placebo

Sponsor

Alnylam Pharmaceuticals